// App-Quantinova.ai

5572 : IMC-F106C, a novel and potent immunotherapy approach to treat PRAME expressing solid and hematologic tumors

Researchers

Presenter

  • Sylvie Moureau

Principal Investigators

  • Alessio Vantellini

  • Florence Schlosser

  • Jacob Robinson

  • Jane Harper

  • Athiva Shankar

  • Greg Dobrynin

  • Gabrielle Le Provost

  • Amanda Williams

  • David Berman

  • Laure Humbert

Medical Centers

  • Immunocore, Ltd, Abingdon, United Kingdom

Locations

  • United Kingdom

Companies

  • Immunocore Ltd

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Acute myelocytic leukemia

  • Ovarian cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Peripheral blood mononuclear cell

  • Major Histocompatibility Complex, Class I, A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved